TrialDiabetes care2012
Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.
Claudia Cavelti-Weder et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
145 papers cite itlatest 60 shown
this paperpooled ittrialcites it